These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25572665)

  • 1. PET/CT predicts survival in patients undergoing primary surgery for esophageal cancer.
    Lindner K; Palmes D; Senninger N; Hummel R
    Langenbecks Arch Surg; 2015 Feb; 400(2):229-35. PubMed ID: 25572665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of 18-FDG PET/CT and EUS-defined tumour characteristics in patients with oesophageal cancer.
    Chan DS; Fielding P; Roberts SA; Reid TD; Ellis-Owen R; Lewis WG
    Clin Radiol; 2013 Apr; 68(4):352-7. PubMed ID: 22981727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of response to neoadjuvant chemotherapy for esophageal cancer using 18F-fluorodeoxiglucose positron emission tomography (18F-FDG-PET).
    Miyata H; Yamasaki M; Takahashi T; Murakami K; Tanaka K; Yukinori K; Nakajima K; Takiguchi S; Morii E; Hatazawa J; Mori M; Doki Y
    Ann Surg Oncol; 2014 Feb; 21(2):575-82. PubMed ID: 24201746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography to Predict Outcomes of Neoadjuvant Chemoradiotherapy Followed by Surgical Treatment for Esophageal Squamous Cell Carcinoma.
    Hamai Y; Hihara J; Emi M; Furukawa T; Yamakita I; Kurokawa T; Okada M
    Ann Thorac Surg; 2016 Oct; 102(4):1132-9. PubMed ID: 27319990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.
    Pfau PR; Perlman SB; Stanko P; Frick TJ; Gopal DV; Said A; Zhang Z; Weigel T
    Gastrointest Endosc; 2007 Mar; 65(3):377-84. PubMed ID: 17321235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.
    Rizk N; Downey RJ; Akhurst T; Gonen M; Bains MS; Larson S; Rusch V
    Ann Thorac Surg; 2006 Mar; 81(3):1076-81. PubMed ID: 16488726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.
    Roedl JB; Harisinghani MG; Colen RR; Fischman AJ; Blake MA; Mathisen DJ; Mueller PR
    Ann Thorac Surg; 2008 Oct; 86(4):1131-8. PubMed ID: 18805147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
    Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
    Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
    Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of baseline positron emission tomography with computed tomography for predicting endoscopic resectability and survival outcomes in patients with early esophageal adenocarcinoma.
    Sun G; Tian J; Gorospe EC; Johnson GB; Hunt CH; Lutzke LS; Leggett CL; Iyer PG; Wang KK
    J Gastroenterol Hepatol; 2013 Jun; 28(6):975-81. PubMed ID: 23425230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between selected tumor markers and fluorodeoxyglucose maximal standardized uptake values in esophageal cancer.
    Taylor MD; Smith PW; Brix WK; Wick MR; Theodosakis N; Swenson BR; Kozower BD; Jones DR
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):699-705. PubMed ID: 19136271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic ultrasound for early stage esophageal adenocarcinoma: implications for staging and survival.
    Crabtree TD; Yacoub WN; Puri V; Azar R; Zoole JB; Patterson GA; Krupnick AS; Kreisel D; Meyers BF
    Ann Thorac Surg; 2011 May; 91(5):1509-15; discussion 1515-6. PubMed ID: 21435632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
    Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of positron emission tomography-computed tomography in predicting survival after neoadjuvant chemotherapy and surgery for oesophageal adenocarcinoma.
    Gillies RS; Middleton MR; Han C; Marshall RE; Maynard ND; Bradley KM; Gleeson FV
    Br J Surg; 2012 Feb; 99(2):239-45. PubMed ID: 22329010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative positron emission tomography/computed tomography predicts advanced lymph node metastasis in esophageal squamous cell carcinoma patients.
    Hsu PK; Lin KH; Wang SJ; Huang CS; Wu YC; Hsu WH
    World J Surg; 2011 Jun; 35(6):1321-6. PubMed ID: 21476114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography/computed tomography and esophageal cancer in the clinical practice: How does it affect the prognosis?
    Cervino AR; Evangelista L; Alfieri R; Castoro C; Sileni VC; Pomerri F; Corti L; Muzzio PC
    J Cancer Res Ther; 2012; 8(4):619-25. PubMed ID: 23361284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of the Maximum Standardized Uptake Value on Positron Emission Tomography for Esophageal Squamous Cell Carcinoma.
    Jeon HW; Kim KS; Sung SW; Park HJ; Kim YD; Park JK
    Thorac Cardiovasc Surg; 2015 Jun; 63(4):341-8. PubMed ID: 25322264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.